Quoin Pharmaceuticals Ownership 2024 | Who Owns Quoin Pharmaceuticals Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.03%

Insider Ownership

0.49%

Retail Ownership

99.49%

Institutional Holders

1.00

Quoin Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023

Quoin Pharmaceuticals's largest institutional shareholder is ADVISORY SERVICES NETWORK, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023

The largest Quoin Pharmaceuticals shareholder by % of total assets is ADVISORY SERVICES NETWORK, LLC. The company owns 0.00 shares of Quoin Pharmaceuticals (QNRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Quoin Pharmaceuticals's largest institutional buyer is ADVISORY SERVICES NETWORK, LLC. The company purchased -2.00K stocks of QNRX, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Quoin Pharmaceuticals's biggest institutional seller is ADVISORY SERVICES NETWORK, LLC. The company sold -2.00K shares of QNRX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023

Quoin Pharmaceuticals's largest sold out institutional shareholder by shares sold is ADVISORY SERVICES NETWORK, LLC, sold -2.00K shares, valued at -, as of undefined.

Quoin Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	14,392	-	-	Nov 30, 2023

Quoin Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 14.39K shares, compromising 0.00% of its total assets.

Quoin Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Jun, 22	8	60.00%
31 Mar, 22	5	25.00%
31 Dec, 21	4	-

As of 31 Mar 23, 1 institutions are holding Quoin Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	2,000	-50.00%
31 Dec, 22	4,000	-
30 Jun, 22	169,917	17.54%
31 Mar, 22	144,562	-31.34%
31 Dec, 21	210,560	-

Quoin Pharmaceuticals (QNRX) has 2.00K shares outstanding as of 31 Mar 23, down -50.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	0.03%	384.12%
31 Dec, 22	0.08%	-
30 Jun, 22	3.51%	39.40%
31 Mar, 22	2.98%	15.80%
31 Dec, 21	4.34%	-

As of 31 Mar 23, Quoin Pharmaceuticals is held by 0.03% institutional shareholders, representing a 384.12% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-
30 Jun, 22	5	25.00%
31 Mar, 22	4	-
31 Dec, 21	4	-

- institutional shareholders have increased their position in QNRX stock as of 31 Mar 23 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	-	-
30 Jun, 22	1	-
31 Mar, 22	1	-
31 Dec, 21	-	-

1 institutional shareholders have reduced their position in QNRX stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	1	-	2,000	-50.00%	0.03%	384.12%	-	-100.00%	1	-
31 Dec, 22	1	-	4,000	-	0.08%	-	1	-	-	-
30 Jun, 22	8	60.00%	169,917	17.54%	3.51%	39.40%	5	25.00%	1	-
31 Mar, 22	5	25.00%	144,562	-31.34%	2.98%	15.80%	4	-	1	-
31 Dec, 21	4	-	210,560	-	4.34%	-	4	-	-	-

Quoin Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Mar 07, 2023	SEMBER MICHAEL T	director	-	Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	LANGER DENNIS	director	-	Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Cooper Joseph Patrick	director	-	Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Culverwell Anthony James	director	-	Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Leong Natalie Ee Mun	director	-	Sell	64,285,600	-	$225.00K	-
Jan 03, 2023	Myers Michael	officer	Chief Executive Officer	Sell	428,571,600	-	$1.50M	-
Jan 03, 2023	Myers Michael	officer	Chief Executive Officer	Sell	-	-	-	561,480,000
Jan 03, 2023	Cooper Joseph Patrick	director	-	Sell	64,285,600	-	$225.00K	-
Jan 03, 2023	Carter Denise P.	officer	Chief Operating Officer	Sell	428,571,600	-	$1.50M	-
Jan 03, 2023	Carter Denise P.	officer	Chief Operating Officer	Sell	-	-	-	561,475,000
Jan 03, 2023	Dunn Gordon	officer	Chief Financial Officer	Sell	357,142,800	-	$1.25M	-
Jan 03, 2023	Culverwell Anthony James	director	-	Sell	64,285,600	-	$225.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Oct 30, 2023	SEMBER MICHAEL T	director	-	A-Award	Buy	7,652	$5.75	$44.00K	7,652
Oct 30, 2023	Dunn Gordon	officer	Chief Financial Officer	A-Award	Buy	51,149	$5.75	$294.11K	51,149
Oct 30, 2023	Myers Michael	director, officer	Chief Executive Officer	A-Award	Buy	80,965	$5.75	$465.55K	80,965
Oct 30, 2023	Culverwell Anthony James	director	-	A-Award	Buy	7,652	$5.75	$44.00K	7,652
Oct 30, 2023	Cooper Joseph Patrick	director	-	A-Award	Buy	7,652	$5.75	$44.00K	7,652
Oct 30, 2023	Leong Natalie Ee Mun	director	-	A-Award	Buy	7,652	$5.75	$44.00K	7,652
Oct 30, 2023	Carter Denise P.	director, officer	Chief Operating Officer	A-Award	Buy	80,966	$5.75	$465.55K	80,966
Oct 30, 2023	LANGER DENNIS	director	-	A-Award	Buy	7,652	$5.75	$44.00K	7,652
Mar 07, 2023	SEMBER MICHAEL T	director	-		Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	LANGER DENNIS	director	-		Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Cooper Joseph Patrick	director	-		Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Culverwell Anthony James	director	-		Sell	64,285,600	-	$225.00K	-
Mar 07, 2023	Leong Natalie Ee Mun	director	-		Sell	64,285,600	-	$225.00K	-
Jan 03, 2023	Myers Michael	officer	Chief Executive Officer		Sell	428,571,600	-	$1.50M	-
Jan 03, 2023	Myers Michael	officer	Chief Executive Officer		Sell	-	-	-	561,480,000
Jan 03, 2023	Cooper Joseph Patrick	director	-		Sell	64,285,600	-	$225.00K	-
Jan 03, 2023	Carter Denise P.	officer	Chief Operating Officer		Sell	428,571,600	-	$1.50M	-
Jan 03, 2023	Carter Denise P.	officer	Chief Operating Officer		Sell	-	-	-	561,475,000
Jan 03, 2023	Dunn Gordon	officer	Chief Financial Officer		Sell	357,142,800	-	$1.25M	-
Jan 03, 2023	Culverwell Anthony James	director	-		Sell	64,285,600	-	$225.00K	-

The last insider sell of Quoin Pharmaceuticals's stock was made by SEMBER MICHAEL T on Mar 07 2023, selling 64,285,600 shares at - per share (valued at $225.00K).

Quoin Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	12	-
Q1 2023	-	4	-

0 total buy trades, and 12 total sell trades (buy/sell ratio of 0.00%) were made by Quoin Pharmaceuticals's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Quoin Pharmaceuticals's stocks.

Quoin Pharmaceuticals Peer Ownership

Ticker	Company
CDIO	Cardio Diagnostics Holdings, Inc.
BDRX	Biodexa Pharmaceuticals Plc
VRAX	Virax Biolabs Group Limited
UNCY	Unicycive Therapeutics, Inc.
BWV	Onconetix, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
HILS	Tharimmune, Inc.
ALLR	Allarity Therapeutics, Inc.

QNRX Ownership FAQ

Who Owns Quoin Pharmaceuticals?

Quoin Pharmaceuticals is owned by institutional shareholders (0.03%), insiders (0.49%), and public (99.49%). The largest institutional shareholder of Quoin Pharmaceuticals is ADVISORY SERVICES NETWORK, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Quoin Pharmaceuticals?

Quoin Pharmaceuticals's major institutional shareholders are ADVISORY SERVICES NETWORK, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Quoin Pharmaceuticals shareholders are there?

As of Mar 2023, there are 1 institutional shareholders of Quoin Pharmaceuticals.

What percentage of Quoin Pharmaceuticals is owned by ADVISORY SERVICES NETWORK, LLC?

ADVISORY SERVICES NETWORK, LLC owns 0 shares of Quoin Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).